Funding, deals, hiring, trials and approvals across biotech, pharma and academia — plus the newest papers in virology, molecular biology, cell biology, NGS, oncology and veterinary medicine, ranked by journal tier and topical fit.
A standing roster of biopharma and life-science tooling companies — 18 tracked.
Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as Perioperative Treatment for Adults With Resectable Muscle-Invasive Bladder Cancer (MIBC)
Yahoo Finance · 2026-09-18
Novartis India acquires Pfizer’s Minipress brands for $150 million
The Pharma Letter · 2026-09-18
Novartis India acquires Pfizer’s Minipress brands for $150 million
The Pharma Letter · 2026-09-18
Novartis receives positive CHMP opinion for Cosentyx® in polymyalgia rheumatica (PMR)
Yahoo Finance · 2026-09-18
Novartis ends ALS program after phase 2 flop, adding to R&D woes
fiercebiotech.com · 2026-09-16
Also watching, nothing this window: Azenta Life Sciences, Humane Genomics, Boehringer Ingelheim, Thermo Fisher, Lexeo Therapeutics, Regeneron, GenScript, UCB, Immunai, Genmab, Insmed, Mount Sinai, Evotec, Kenvue, Rocket Pharmaceuticals
Highest-scoring work indexed this window, one per field.
| Virology | |
| Molecular Biology | |
| Cell Biology | |
| NGS / Genomics | |
| Oncology | |
| Veterinary Medicine |
Ordered by how many independent outlets ran the story
U.S. FDA approves Inluriyo (imlunestrant) in combination with Verzenio (abemaciclib) for adults with ER+, HER2-, ESR1-mutated advanced or metastatic breast cancer Eli Lilly
First Gene Therapy for Sanfilippo Syndrome Type A Gets FDA Approval - MPR Medical Professionals Reference
PDS Biotech Announces Initial Closing of up to $22.3 Million PIPE Financing and the Appointment of Dr. Patrick Soon-Shiong to Its Board of Directors manilatimes.net
FDA approves pioneering breast cancer drug that nips resistance in the bud Nature
CHMP Backs Perioperative Pembrolizumab Plus Enfortumab Vedotin for Resectable MIBC OncLive
PharmAla Biotech (MDMA.CN) Appoints Davidson & Company as Auditor, Partners with Watertower Research and Oak Hill Advisory Kalkine Media
Dividend stocks alert, record date: Last chance to buy - Blue Dart, Karnataka Bank, Aarti Pharma, ITDC | Full list TradingView
Is Elanco Animal Health (ELAN) Undervalued As Growth Expectations Meet A Recent Pullback? Yahoo Finance
Gland Pharma to acquire 100% stake in US subsidiary for US$ 501,208 Indian Pharma Post
Scientists target gum disease with bacteriophage virus medicalxpress.com
Financings, IPOs, venture rounds
PDS Biotech Raises $11.3 Million in Initial PIPE Led by Patrick Soon-Shiong citybiz
PDS Biotech Announces Initial Closing Of Up To $22.3 Mln PIPE Financing TradingView
Retension Pharmaceuticals, TRex Bio file for US IPO as biotech momentum continues Reuters
Mithrl Raises $20M to Bring Custom AI Infrastructure to Biopharma, Grounded in Its Biomedical World Model Business Wire
Mithrl raises $20M Series A for biopharma AI infrastructure Dealroom
M&A, licensing, reverse mergers
Gland Pharma to acquire 100% stake in Gland Pharma USA TradingView
Sudarshan Pharma Says Proposed 9.5% Stake Acquisition in US Firm Under Due Diligence First India
North Immunology joins biotech reverse merger boom with Aethlon deal BioPharma Dive
A Parkinson’s biotech debut, fundraising campaign and licensing deal Endpoints News
Australia's Telix Pharma agrees to buy Germany's ITM Isotope for about $1.65 billion Reuters
Hires, exits, layoffs, restructurings
HAB Pharma Appoints Pankaj Agarwal As Chief Financial Officer BW People
PharmAla Biotech Appoints Davidson & Company as Auditor, Retains Water Tower Research and Oak Hill Financial kalkine.ca
PharmAla Biotech (MDMA.CN) Appoints Davidson & Company Auditor, Engages Watertower Research and Oak Hill Advisory kalkine.ca
Mankind Pharma Appoints Anish Bafna as Independent Director Veloxx media
mlHealth360 appoints Prashant Naidu as Chief Business Officer for India, Emerging Markets Indian Pharma Post
Readouts, starts, failures
GENFIT Advances Nangibotide in Phase 2 Clinical Investigation in ACLF Yahoo Finance UK
Bezisterim may help with some Long COVID symptoms, drug’s developer reports in early trial results The Sick Times
Vera kidney drug Trutakna shows strong final results in Phase 3 trial statnews.com
Encouraging news from Skyhawk, as SKY-0515 Phase 1/2 data continues to hold promise HDBuzz – Huntington’s disease research news.
Optimi Health Expands Clinical Program with Phase 3 Trial Evaluating MDMA-Assisted Therapy for Post-Traumatic Stress Disorder Yahoo Finance
Approvals, CRLs, CHMP opinions
FDA Approves Imlunestrant in Combination With Abemaciclib for ER-Positive, HER2-Negative, ESR1-Mutated Advanced or Metastatic Breast Cancer The ASCO Post
FDA Approves Inluriyo Plus Verzenio for Certain Advanced Breast Cancers Cure Today
FDA Approves Imlunestrant Plus Abemaciclib for ESR1-Mutated, ER-Positive, HER2-Negative Advanced Breast Cancer Oncology Nursing News
FDA Approves Imlunestrant Plus Abemaciclib in ESR1-Mutated Breast Cancer Targeted Oncology
FDA Approves Imlunestrant Plus Abemaciclib for ER+, HER2–, ESR1-Mutated Metastatic Breast Cancer OncLive
Grants, budgets, institutions
AUM awarded $508K NIH grant to study work, well-being, and financial stress in adults with Down syndrome WBRC
Scientists challenge US NIH grant screening as unconstitutional Reuters
How research funding took me out of the lab and into leadership Nature
Trump seeks to bring health-research funding under his control, Politico reports Reuters
NGS, virology and animal-health industry moves
Scientists use virus to dismantle gum disease bacteria nzdoctor.co.nz
Oxford Nanopore Secures Preliminary Injunction Against MGI CycloneSEQ Systems in European Patent Dispute Yahoo Finance UK
Oxford Nanopore Technologies (ONT) Secures Preliminary Injunction Against MGI Tech GmbH Over CycloneSEQ Patent Violations Kalkine Media
Stifel reiterates Elanco Animal Health stock rating on Befrena outlook Investing.com
Elanco Animal Health stock gains on Stifel buy rating and strong Q2 figures AD HOC NEWS